A decrease in newly diagnosed patients with adult T-cell leukemia/lymphoma in Kagoshima, a highly endemic area of HTLV-1 in southwestern Japan

References

• Uchiyama T, Yodoi J, Sagawa K, et al. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50(3):481–492.
   PubMed Web of Science ®Google Scholar
• Poiesz BJ, Ruscetti FW, Gazdar AF, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980;77(12):7415–7419.
   PubMed Web of Science ®Google Scholar
• Ishitsuka K, Tamura K. Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. Lancet Oncol. 2014;15(11):e517-526–e526.
   Web of Science ®Google Scholar
• Gessain A, Cassar O. Epidemiological Aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:388.
   PubMed Web of Science ®Google Scholar
• Shimoyama M, members of The Lymphoma Study Group (1984–87)* Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the lymphoma study group (1984-87). Br J Haematol. 1991;79(3):428–437.
   PubMed Web of Science ®Google Scholar
• Hermine O, Ramos JC, Tobinai K. A Review of new findings in adult T-cell Leukemia-Lymphoma: a focus on current and emerging treatment strategies. Adv Ther. 2018;35(2):135–152.
   PubMed Web of Science ®Google Scholar
• Tajima K. The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-cell malignancy study group. Int J Cancer. 1990;45(2):237–243.
   PubMed Web of Science ®Google Scholar
• Satake M, Yamaguchi K, Tadokoro K. Current prevalence of HTLV-1 in Japan as determined by screening of blood donors. J Med Virol. 2012;84(2):327–335.
   PubMed Web of Science ®Google Scholar
• Hamaguchi I. Current status of HTLV-1 infection. Neuroinfection. 2020;25(1):92–94. [Japanese]
   Google Scholar
• Kinoshita K, Hino S, Amagaski T, et al. Demonstration of adult T-cell leukemia virus antigen in milk from three sero-positive mothers. Gan. 1984;75(2):103–105.
   PubMedGoogle Scholar
• Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, et al. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005;24(39):6058–6068.
   PubMed Web of Science ®Google Scholar
• Hino S. Establishment of the milk-borne transmission as a key factor for the peculiar endemicity of human T-lymphotropic virus type 1 (HTLV-1): the ATL prevention program Nagasaki. Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(4):152–166.
   PubMed Web of Science ®Google Scholar
• Percher F, Jeannin P, Martin-Latil S, et al. Mother-to-Child transmission of HTLV-1 epidemiological aspects, mechanisms and determinants of mother-to-Child transmission. Viruses. 2016;8(2):40.
   PubMed Web of Science ®Google Scholar
• Take H, Umemoto M, Kusuhara K, et al. Transmission routes of HTLV-I: an analysis of 66 families. Jpn J Cancer Res. 1993;84(12):1265–1267.
   PubMedGoogle Scholar
• Miyazawa T, Hasebe Y, Murase M, et al. The Effect of early postnatal nutrition on human T cell leukemia virus type 1 mother-to-Child transmission: a systematic review and Meta-Analysis. Viruses. 2021;13(5):819.
   PubMed Web of Science ®Google Scholar
• Iwanaga M, Watanabe T, Yamaguchi K. Adult T-cell leukemia: a review of epidemiological evidence. Front Microbiol. 2012;3:322.
   PubMed Web of Science ®Google Scholar
• Nosaka K, Iwanaga M, Imaizumi Y, et al. Epidemiological and clinical features of adult T-cell leukemia-lymphoma in Japan, 2010-2011: a nationwide survey. Cancer Sci. 2017;108(12):2478–2486.
   PubMed Web of Science ®Google Scholar
• Katsuya H, Ishitsuka K, Utsunomiya A, ATL-Prognostic Index Project, et al. Treatment and survival among 1594 patients with ATL. Blood. 2015;126(24):2570–2577.
   PubMed Web of Science ®Google Scholar
• Imaizumi Y, Iwanaga M, Nosaka K, for collaborative Investigators, et al. Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: a nationwide hospital-based study. Cancer Sci. 2020;111(12):4567–4580.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Atogami S, Hasegawa H, et al. [Nationwide survey of adult T-cell leukemia/lymphoma (ATL) in Japan]. Rinsho Ketsueki. 2011;52(11):1765–1771. [Japanese]
   PubMedGoogle Scholar
• Ministry of Health, Labour and Welfare. Special Vital Statistics Report for Fiscal Year 2017. Summary of Age-Adjusted Mortality Rates by Prefecture in 2015. 2022. https://www.mhlw.go.jp/toukei/saikin/hw/jinkou/other/15sibou/index.html
   Google Scholar
• Ito S, Iwanaga M, Nosaka K, Collaborative Investigators, et al. Epidemiology of adult T-cell leukemia-lymphoma in Japan: an updated analysis, 2012-2013. Cancer Sci. 2021;112(10):4346–4354.
   PubMed Web of Science ®Google Scholar
• Chihara D, Ito H, Matsuda T, et al. Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol. 2014;164(4):536–545.
   PubMed Web of Science ®Google Scholar
• Nerome Y, Kojyo K, Ninomiya Y, et al. Current human T-cell lymphotropic virus type 1 mother-to-child transmission prevention status in Kagoshima. Pediatr Int. 2014;56(4):640–643.
   PubMed Web of Science ®Google Scholar
• Oki T, Yoshinaga M, Otsuka H, et al. A sero-epidemiological study on mother-to-child transmission of HTLV-I in Southern kyushu, Japan. Asia Oceania J Obstet Gynaecol. 1992;18(4):371–377.
   PubMedGoogle Scholar
• Satake M, Iwanaga M, Sagara Y, et al. Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in Japan: a nationwide retrospective cohort analysis. Lancet Infect Dis. 2016;16(11):1246–1254.
   PubMed Web of Science ®Google Scholar
• Tashiro Y, Matsuura E, Sagara Y, et al. High Prevalence of HTLV-1 carriers among the elderly population in Kagoshima, a highly endemic area in Japan. AIDS Res Hum Retroviruses. 2022;38(5):363–369.
   PubMed Web of Science ®Google Scholar
• Millen S, Thoma-Kress AK. Milk Transmission of HTLV-1 and the need for innovative prevention strategies. Front Med (Lausanne). 2022;9:867147.
   PubMed Web of Science ®Google Scholar
• Du J, Chen C, Gao J, et al. History and update of HTLV infection in China. Virus Res. 2014;191:134–137.
   PubMed Web of Science ®Google Scholar
• Chang YB, Kaidarova Z, Hindes D, et al. Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors–United States, 2000-2009. J Infect Dis. 2014;209(4):523–531.
   PubMed Web of Science ®Google Scholar
• Manns A, Wilks RJ, Murphy EL, et al. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer. 1992;51(6):886–891.
   PubMed Web of Science ®Google Scholar
• Chihara D, Ito H, Katanoda K, et al. Increase in incidence of adult T-cell leukemia/lymphoma in non-endemic areas of Japan and the United States. Cancer Sci. 2012;103(10):1857–1860.
   PubMed Web of Science ®Google Scholar
• Iwanaga M. Epidemiology of HTLV-1 infection and ATL in Japan: an update. Front Microbiol. 2020;11:1124.
   PubMed Web of Science ®Google Scholar